Skip to main content
. 2020 Aug 4;160(1):115–127.e30. doi: 10.1053/j.gastro.2020.07.048

Supplementary Table 7.

Change in Microbiome Composition (β-Diversity) Post-Treatment Compared With Placebo

Treatment group compared with placebo/placebo Days post treatment P value (unadjusted) Placebo/placebo mean Treatment group mean
Placebo/SER-287 weekly 0 .769 0.330 0.329
3 .701 0.317 0.296
7 .469 0.288 0.339
10 .871 0.265 0.354
14 .733 0.326 0.342
56 .517 0.340 0.400
84 .626 0.421 0.443
Vancomycin/SER-287 daily 0 .003 0.330 0.865
3 .001 0.317 0.775
7 .001 0.288 0.747
10 .001 0.265 0.663
14 .001 0.326 0.672
56 .002 0.340 0.650
84 .067 0.421 0.680
Vancomycin/SER-287 weekly 0 .002 0.330 0.906
3 <.001 0.317 0.841
7 <.001 0.288 0.775
10 .001 0.265 0.718
14 <.001 0.326 0.654
56 .001 0.340 0.601
84 .092 0.421 0.606

NOTE. β-diversity distance (binary Jaccard) from baseline for subjects in each treatment group at the given time point, compared with placebo. P value indicates 2-sided Mann Whitney U test for the indicated treatment arm compared with placebo. See Supplementary Table 2 for the number of subjects.